Publications by authors named "Geoff D Hall"

Claim this Profile
A
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.
Amit M Oza, Ursula A Matulonis, Angeles Alvarez Secord, John Nemunaitis, Lynda D Roman, Geoff D Hall

Clin Cancer Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing glomerular filtration rate equations and the impact of different creatinine assays on the assessment of renal function in cancer patients.
Ashley E Garner, Mark C Barnfield, Michael L Waller, Geoff D Hall, Mike P Bosomworth

Ann Clin Biochem· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy number signatures and mutational processes in ovarian carcinoma.
Geoff Macintyre, Teodora E Goranova, Dilrini De Silva, Darren Ennis, Anna M Piskorz, Geoff D Hall, Marcia Hall

Nat Genet· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NuMA overexpression in epithelial ovarian cancer.
Anke Brüning-Richardson, Jaqueline Bond, Rawiah Alsiary, Julie Richardson, David A Cairns, Geoff D Hall

PLoS One· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies.
Eleni M Karapanagiotou, Victoria Roulstone, Katie Twigger, Mercel Ball, Maryanne Tanay, Geoff D Hall

Clin Cancer Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma.
Naveen S Vasudev, Ioannis Trigonis, David A Cairns, Geoff D Hall, David P Jackson

Arch Gynecol Obstet· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of antiangiogenic agents for ovarian cancer.
Fiona J Collinson, Geoff D Hall, Timothy J Perren, Gordon C Jayson

Expert Rev Anticancer Ther· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis